[후생신보] Samsung Medison takes the lead in distributing ultrasound technology for quantifying fatty liver

2023-05-11 07:43:00

[Welfare News]Samsung Medison is actively working to spread ultrasound technology for convenient and intuitive fat liver quantification for the management of non-alcoholic fatty liver, which is rapidly increasing.

Samsung Medison announced that it announced research results using the premium ultrasound diagnostic device ‘RS85 Prestige’ and V8 at the 54th Korean Society of Ultrasound Medicine (KSUM 2023) held at COEX in Samseong-dong, Seoul from May 11 to 13.

The ultrasound technology used for fat liver quantification was RS85 Prestige, and the probe for prostate ultrasound (the part that transmits and receives ultrasound signals) used V8.

At the Luncheon Symposium held on May 11 under the theme of ‘Quantitative Ultrasound (QUS)’, ‘TAI Tissue Attenuation Imaging’ and ‘TSI Tissue Scatter-distribution’ used to quantify the amount of fat in the liver were presented. Imaging)’ technology was announced.

‘TAI’ is a technology that quantifies fatty liver by measuring the degree to which ultrasound signals are weakened by fat in liver cells.

In addition, ‘TSI’ is a technology that quantifies fatty liver by measuring the degree to which fat in liver cells scatters ultrasound waves.

Professor Lee Jeong-min of the Department of Radiology at Seoul National University Hospital, who was the speaker of ‘Quantitative Evaluation of Fatty Liver Using Ultrasound Imaging Technique’, presented the research result that ‘TAI’ and ‘TSI’ technology were able to quantitatively evaluate the severity of non-alcoholic fatty liver. Samsung’s QUS shows the amount of fat in the liver as a percentage, so doctors and patients can intuitively recognize the seriousness of fatty liver and expect to receive treatment.”

Along with this, in an academic session on the same day, Seoul National University Bundang Hospital Department of Radiology Professor Seong-Il Hwang discussed how much the mini probe (miniER7) developed by Samsung Medison can reduce pain and discomfort felt by patients compared to the existing probe (EA2-11AR) and how it can be used for diagnosis. Published research results comparing required image quality.

Professor Hwang Seong-il said, “As a result of the study, the NRS Numerical Rating Scale of patients with the conventional probe and the mini-probe decreased from 4.7 to 2.7, and the image quality was 4.78 and 4.74, respectively, showing little difference.”

The numerical pain scale is 0 (no pain), 1 to 3 (mild pain), 4 to 6 (moderate pain), 7 to 9 (severe pain), and 10 (maximum pain), and image quality is evaluated qualitatively on a 5-point scale. do.

In particular, he emphasized, “The study was conducted using Samsung Medison’s ultrasound diagnostic device V8,” and “a patient’s pain was reduced by 43% without deteriorating image quality during prostate ultrasound using a mini probe.”

Meanwhile, Vice President Gyu-Tae Yoo, Head of Strategic Marketing Team at Samsung Medison, said, “I hope that Samsung’s convenient and intuitive ultrasound technology for fat liver quantification will be widely used for the management of non-alcoholic fatty liver, which is rapidly increasing.” We will continue to listen to the voices of the field in the future with solutions that reflect the issues.”

1683796195
#후생신보 #Samsung #Medison #takes #lead #distributing #ultrasound #technology #quantifying #fatty #liver

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.